- Home
- Publications
- Publication Search
- Publication Details
Title
CCR6 as a possible therapeutic target in psoriasis
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 14, Issue 9, Pages 911-922
Publisher
Informa Healthcare
Online
2010-07-15
DOI
10.1517/14728222.2010.504716
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronically Inflamed Human Tissues Are Infiltrated by Highly Differentiated Th17 Lymphocytes
- (2014) J. Pene et al. JOURNAL OF IMMUNOLOGY
- Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer
- (2010) Lin Xu et al. CLINICAL IMMUNOLOGY
- CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC
- (2010) Lara E. Kallal et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Anti-chemokine small molecule drugs: a promising future?
- (2010) Amanda EI Proudfoot et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Natural killer cells in atopic and autoimmune diseases of the skin
- (2010) Dagmar von Bubnoff et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Human NKp44+IL-22+cells and LTi-like cells constitute a stable RORC+lineage distinct from conventional natural killer cells
- (2010) Natasha K. Crellin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-7 and IL-15 independently program the differentiation of intestinal CD3−NKp46+cell subsets from Id2-dependent precursors
- (2010) Naoko Satoh-Takayama et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility
- (2010) Yuta Kochi et al. NATURE GENETICS
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
- (2010) Christopher E.M. Griffiths et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis
- (2010) Mona Gandhi et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Chemokines as Novel Therapeutic Targets for Inflammatory Bowel Disease
- (2009) Miyuki Nishimura et al. Annals of the New York Academy of Sciences
- Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis
- (2009) L. Melis et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
- (2009) Eihab A. Alwawi et al. Dermatologic Therapy
- The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: A novel immunological cascade with potential relevance in psoriasis
- (2009) Kerstin Wolk et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Chemokine receptor antagonists: part 2
- (2009) James E Pease et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Chemokine receptor antagonists: Part 1
- (2009) James E Pease et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Maraviroc: a new CCR5 antagonist
- (2009) Shilpa Sayana et al. Expert Review of Anti-Infective Therapy
- Promiscuous drugs as therapeutics for chemokine receptors
- (2009) Richard Horuk EXPERT REVIEWS IN MOLECULAR MEDICINE
- Chemokines and chemokine receptors: an overview
- (2009) Raffaella Bonecchi Frontiers in Bioscience-Landmark
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
- (2009) Natalia Martin-Orozco et al. IMMUNITY
- IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells
- (2009) Kristine E. Nograles et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CCR6 is required for IL-23–induced psoriasis-like inflammation in mice
- (2009) Michael N. Hedrick et al. JOURNAL OF CLINICAL INVESTIGATION
- Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling
- (2009) Katia Boniface et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD56highCD16-CD62L- NK Cells Accumulate in Allergic Contact Dermatitis and Contribute to the Expression of Allergic Responses
- (2009) T. Carbone et al. JOURNAL OF IMMUNOLOGY
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
- (2009) L. van der Fits et al. JOURNAL OF IMMUNOLOGY
- Inhibition of CCR6 Function Reduces the Severity of Experimental Autoimmune Encephalomyelitis via Effects on the Priming Phase of the Immune Response
- (2009) A. Liston et al. JOURNAL OF IMMUNOLOGY
- Natural Killer T Cells: An Unconventional T-Cell Subset with Diverse Effector and Regulatory Functions
- (2009) Anna Balato et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines
- (2009) Consuelo Ortega et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Treatments for psoriasis and the risk of malignancy
- (2009) Rita V. Patel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
- (2009) Alice Gottlieb et al. LANCET
- Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells
- (2009) Sara Trifari et al. NATURE IMMUNOLOGY
- Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
- (2009) Thomas Duhen et al. NATURE IMMUNOLOGY
- Plerixafor
- (2009) John F. DiPersio et al. NATURE REVIEWS DRUG DISCOVERY
- β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin
- (2009) Patrick A. M. Jansen et al. PLoS One
- Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides
- (2008) Camilla Jandus et al. ARTHRITIS AND RHEUMATISM
- Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model
- (2008) Asahi Ito et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection
- (2008) Sharon S. Lieberman-Blum et al. CLINICAL THERAPEUTICS
- Chemokines and other mediators as therapeutic targets in psoriasis vulgaris
- (2008) Bernhard Homey et al. CLINICS IN DERMATOLOGY
- Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseases
- (2008) Alicja Kalinowska et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A novel CXCR4 antagonist for hematopoietic stem cell mobilization
- (2008) Simon P Fricker EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
- (2008) Wenjun Ouyang et al. IMMUNITY
- Microbial Flora Drives Interleukin 22 Production in Intestinal NKp46+ Cells that Provide Innate Mucosal Immune Defense
- (2008) Naoko Satoh-Takayama et al. IMMUNITY
- Differential mRNA Expression of Antimicrobial Peptides and Proteins in Atopic Dermatitis as Compared to Psoriasis Vulgaris and Healthy Skin
- (2008) Thilo Gambichler et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial
- (2008) M. Caproni et al. JOURNAL OF CLINICAL IMMUNOLOGY
- In vivo equilibrium of proinflammatory IL-17+and regulatory IL-10+Foxp3+RORγt+T cells
- (2008) Matthias Lochner et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T-Helper 17 Cells in Psoriatic Plaques and Additional Genetic Links between IL-23 and Psoriasis
- (2008) Andrew Blauvelt JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Polymorphisms of the IL12B and IL23R Genes Are Associated with Psoriasis
- (2008) Rajan P. Nair et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells
- (2008) Lisa C. Zaba et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Skin Equivalent and Natural Killer Cells: A New Model for Psoriasis and GVHD
- (2008) Richard S. Kalish et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
- (2008) Marina Cella et al. NATURE
- Moving targets: cell migration inhibitors as new anti-inflammatory therapies
- (2008) Charles R Mackay NATURE IMMUNOLOGY
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt
- (2008) Nicolas Manel et al. NATURE IMMUNOLOGY
- Review Paper: Preclinical Models of Psoriasis
- (2008) D. M. Danilenko VETERINARY PATHOLOGY
- Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
- (2007) Antonella Viola et al. Annual Review of Pharmacology and Toxicology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now